The psychedelic drugs market is expected to grow significantly by 2035, with some reports suggesting it could reach between $12.40 billion and $14.90 billion. The market's growth is reportedly driven by increasing mental health awareness and treatment innovation. However, the exact size and growth rate of the market, as well as its relationship to related markets such as antidepressant and anxiety disorder treatment, are not consistently reported across different forecasts.